Efficacy and Safety of Botulinum Toxin A for Treating Bladder Hyperactivity in Children and Adolescents with Neuropathic Bladder Secondary to Myelomeningocele
Figure 1
Multipoint injection scheme (1 cm3 = 10 IU of BTX-A injected in 20 sites, sparing periureteral areas).